Concepedia

Christopher Matheny

CM

18

Publications

1.1K

Citations

13

H-Index

2000

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Celldex Therapeutics (United States)

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Christopher Matheny is an author at GlaxoSmithKline (United States) specializing in medicine, immunology, and pharmacology.

ORCID

Top concepts

Publications per year

2000–2023

18

Publications

18

Clinical trial links oncolytic immunoactivation to survival in glioblastoma

Alexander Ling, Isaac H. Solomon, Ana Montalvo Landivar et al. · Nature · 2023 · 214 citations · Full text

Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i> -Rearranged Cancers

Alexander Drilon, Romel Somwar, Biju Mangatt et al. · Cancer Discovery · 2018 · 198 citations · Full text

Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification

Jonathan Larkin, Tessa Lohr, Louis Elefante et al. · Osteoarthritis and Cartilage · 2015 · 114 citations · Full text

Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5

Stéphane Mouly, Christopher Matheny, Mark Paine et al. · Clinical Pharmacology & Therapeutics · 2005 · 100 citations

An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation

Sanjay Kumar, Christopher Matheny, Sandra J. Hoffman et al. · Bone · 2009 · 79 citations

, , +8

Rows per page

1–5 of 18